
N-Nitroso Evocalcet NEW
Price | Get Latest Price | ||
Package | 5mg | 20mg | 50mg |
Min. Order: | 1mg |
Supply Ability: | 10000 |
Update Time: | 2025-06-18 |
Product Details
Product Name: N-Nitroso Evocalcet | CAS No.: 3051508-93-8 |
Min. Order: 1mg | Purity: >95% HPLC |
Supply Ability: 10000 | Release date: 2025/06/18 |
Molecular Formula:: C24H25N3O3 | Mol. Weight:: 403.47 |
Appearance: : Brown soild |
Product Catalog: | E056007 |
CAS No.: | 3051508-93-8 |
Product Name: | N-Nitroso Evocalcet |
Purity: | >95% HPLC |
Synonyms: | 2-(4-((S)-3-(((R)-1-(naphthalen-1-yl)ethyl)(nitroso)amino)pyrrolidin-1-yl)phenyl)acetic acid |
Molecular Formula: | C24H25N3O3 |
Mol. Weight: | 403.47 |
Appearance: | Brown soild |
Storage: | 2-8°C Refrigerator |
Contact: | WhatsAPP: +86 17320513646 E-mail: anna@molcoo.com |
Note: | We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS. This product is intended for laboratory use only! |
Background: | N - Nitroso Evocalcet is an impurity that may be present in evocalcet. Evocalcet is a new - generation oral calcimimetic agent used for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. It was first approved for marketing in Japan in March 2018. N - nitroso compounds are well - known potential carcinogens, which may be formed during the synthesis, storage or degradation of drugs. Therefore, the existence of N - Nitroso Evocalcet may pose a potential threat to the safety of evocalcet drugs. |
Company Profile Introduction
1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability.
2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs.
3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects.
4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes.
5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/5kg |
VIP1Y
|
Guangzhou Tosun Pharmaceutical Ltd
|
2024-12-27 | |
$31.00/5mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-07-21 | |
$0.00/10mg |
VIP2Y
|
ShenZhen H&D Pharmaceutical Technology Co., LTD
|
2025-03-19 |
INQUIRY